Description: Accelerated Underwriting – Two Studies (Delphi and SOA Survey)

Description: After the bid process, desk review, rebate reallocation, an “enjoyable” audit, and open enrollment; the Medicare plan year starts. Throughout the year, organizations find it pertinent to get an accurate picture of their Part D liability as reinsurance, LICS (Low Income Cost-Sharing) subsidy, and risk corridors are accrued. Attendees will learn about the basics of Part D accruals, how future accrual amounts are estimated based on patterns in the data, and how bid assumptions versus actual results impact plan sponsor profitability. We will also discuss financial statement treatment of these items. Real-life examples from bids to outcomes will be provided to enhance the discussion. Ultimately, attendees will come away with a deeper understanding how their bid assumptions play out, and how they can use Part D accruals to plan for future bid development.

Description: We will determine the role of risk function in evaluating operational risks associated with the implementation of LDTI and any system conversions. Are all models validated by the risk function before they are productionalized and results used by management to make business decisions? Does the risk function play a part in to assist finance, actuarial and investor relations in communicating changes and volatility resulting from LDTI? If not, should it? We will articulate the role that risk functions play in being part of large transformation from the start as a stakeholder/input provider to subsequently being an independent reviewer (i.e., second Line of defense).

Description: US pharmacy prices have entered a new era of growth driven by Specialty medications. A bevy of state and national regulations have been proposed to address pharmacy pricing, industry structure and transparency.Health actuaries will learn about US pharmacy pricing structure and how proposed legislation could affect future costs. Actuaries that have responsibility for pharmacy rate/budget setting, RFPs or trend projection will benefit from a deeper understanding of the US pharmacy market landscape and gain an international perspective.

Description: Hear an update on the Product Development Section's initiatives over the past year while enjoying a hot breakfast.

Description: Milliman Risk Score will now consider an applicant's Rx and Credit Data. RGA has developed a comprehensive DHD platform and scoring algorithm to transform raw DHD into actionable underwriting assessments. Both new tools will be presented.

Description: James Glickman delivers his general session speech at the SOA 2019 SOA Annual Meeting & Exhibit in Toronto.

Description: "Visual storytelling is frequently used to effectively convey complex actuarial concepts to our clients and other audiences. When talking about data visualization, we often focus on the explanatory aspect. But data visualization is also a crucial tool in developing insights from large and complex data sets at every stage of data analytics spectrum: • descriptive (what happened?), • diagnostic (why it happened?), • predictive (what will happen?), • and prescriptive (how do I influence what will happen?). In exploratory and modeling stages of data analytics’ project, we let the data tell the story or explore our intuition and hypothesis through data pictures. We demonstrate the power of visual display in healthcare data analytics through vivid examples from the healthcare case studies. These illustrations of data visualization exploratory power range from assessing the quality of data or examining outliers, to exploring variables’ relationships and trends, to hypothesis testing, to guiding in feature selection and models’ comparison and evaluation, to model validation. Throughout these illustrations, we will discuss principles of graphical effectiveness, excellence and integrity."

Description: Life insurers in the worksite market face some unique challenges. This session will discuss the valuation findings from a 2019 survey of worksite life companies. Topics will include: Implementation of VM-20 and 2017 CSO Reserving of combination life and health riders, such as chronic or critical illness riders

Description: Learn the fundamentals, promises and myths of blockchain technology; why it's important and relevant today, and how it's evolving our relationships with data, analytics and the science of product development and maintenance. Discuss examples and details with Susan Joseph, and Truman Esmond, VP Solutions and Partnerships for AAIS and Technical Lead for openIDL, AAIS's blockchain network for regulatory reporting.